Work

A sponsor-held platform IND model for personalized immunotherapy.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e23044

Authors: Julianna Lisziewicz, Andras Szasz, Tamas Kos, Abris Heisz, Sti Forstenlehner, Oliver Wueseke, Franco Lori

Institution: Semmelweis University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162682573

Cites:

Cited by:

Related to: